BIOMAT Database Logo BIOMAT Database Logo

Identification of a Src kinase SH3 binding site in the C-terminal domain of the human ErbB2 receptor tyrosine kinase. 2014

Olivier Bornet, and Matthieu Nouailler, and Michaël Feracci, and Corinne Sebban-Kreuzer, and Deborah Byrne, and Hubert Halimi, and Xavier Morelli, and Ali Badache, and Françoise Guerlesquin
IMM, CNRS, Aix-Marseille Université, 31 chemin J. Aiguier, 13402 Marseille Cedex 20, France.

Overexpression of the ErbB2 receptor tyrosine kinase is associated with most aggressive tumors in breast cancer patients and is thus one of the main investigated therapeutic targets. Human ErbB2 C-terminal domain is an unstructured anchor that recruits specific adaptors for signaling cascades resulting in cell growth, differentiation and migration. Herein, we report the presence of a SH3 binding motif in the proline rich unfolded ErbB2 C-terminal region. NMR analysis of this motif supports a PPII helix conformation and the binding to Fyn-SH3 domain. The interaction of a kinase of the Src family with ErbB2 C-terminal domain could contribute to synergistic intracellular signaling and enhanced oncogenesis.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D018719 Receptor, ErbB-2 A cell surface protein-tyrosine kinase receptor that is overexpressed in a variety of ADENOCARCINOMAS. It has extensive homology to and heterodimerizes with the EGF RECEPTOR, the ERBB-3 RECEPTOR, and the ERBB-4 RECEPTOR. Activation of the erbB-2 receptor occurs through heterodimer formation with a ligand-bound erbB receptor family member. HER-2 Proto-Oncogene Protein,Proto-Oncogene Protein HER-2,Proto-Oncogene Protein p185(neu),c-erbB-2 Protein,erbB-2 Proto-Oncogene Protein,erbB-2 Receptor Protein-Tyrosine Kinase,neu Proto-Oncogene Protein,Antigens, CD340,CD340 Antigen,Erb-b2 Receptor Tyrosine Kinases,Metastatic Lymph Node Gene 19 Protein,Neu Receptor,Oncogene Protein HER-2,Proto-Oncogene Proteins c-erbB-2,Proto-oncogene Protein Neu,Receptor, Neu,Receptors, erbB-2,Tyrosine Kinase-type Cell Surface Receptor HER2,p185(c-neu),p185erbB2 Protein,CD340 Antigens,Erb b2 Receptor Tyrosine Kinases,ErbB-2 Receptor,HER 2 Proto Oncogene Protein,Oncogene Protein HER 2,Proto Oncogene Protein HER 2,Proto Oncogene Proteins c erbB 2,Proto-Oncogene Protein, HER-2,Proto-Oncogene Protein, erbB-2,Proto-Oncogene Protein, neu,Tyrosine Kinase type Cell Surface Receptor HER2,c erbB 2 Protein,erbB 2 Proto Oncogene Protein,erbB 2 Receptor Protein Tyrosine Kinase,erbB-2 Receptors,neu Proto Oncogene Protein

Related Publications

Olivier Bornet, and Matthieu Nouailler, and Michaël Feracci, and Corinne Sebban-Kreuzer, and Deborah Byrne, and Hubert Halimi, and Xavier Morelli, and Ali Badache, and Françoise Guerlesquin
A Myristoyl-Binding Site in the SH3 Domain Modulates c-Src Membrane Anchoring.
February 2019, iScience,
Olivier Bornet, and Matthieu Nouailler, and Michaël Feracci, and Corinne Sebban-Kreuzer, and Deborah Byrne, and Hubert Halimi, and Xavier Morelli, and Ali Badache, and Françoise Guerlesquin
Identification of a binding site in c-Ab1 tyrosine kinase for the C-terminal repeated domain of RNA polymerase II.
July 1996, Molecular and cellular biology,
Olivier Bornet, and Matthieu Nouailler, and Michaël Feracci, and Corinne Sebban-Kreuzer, and Deborah Byrne, and Hubert Halimi, and Xavier Morelli, and Ali Badache, and Françoise Guerlesquin
Structural basis for domain-domain communication in a protein tyrosine kinase, the C-terminal Src kinase.
April 2006, Journal of molecular biology,
Olivier Bornet, and Matthieu Nouailler, and Michaël Feracci, and Corinne Sebban-Kreuzer, and Deborah Byrne, and Hubert Halimi, and Xavier Morelli, and Ali Badache, and Françoise Guerlesquin
Intertwined dimeric structure for the SH3 domain of the c-Src tyrosine kinase induced by polyethylene glycol binding.
February 2009, FEBS letters,
Olivier Bornet, and Matthieu Nouailler, and Michaël Feracci, and Corinne Sebban-Kreuzer, and Deborah Byrne, and Hubert Halimi, and Xavier Morelli, and Ali Badache, and Françoise Guerlesquin
Association of Src tyrosine kinase with a human potassium channel mediated by SH3 domain.
December 1996, Science (New York, N.Y.),
Olivier Bornet, and Matthieu Nouailler, and Michaël Feracci, and Corinne Sebban-Kreuzer, and Deborah Byrne, and Hubert Halimi, and Xavier Morelli, and Ali Badache, and Françoise Guerlesquin
Molecular basis for the interaction between human choline kinase alpha and the SH3 domain of the c-Src tyrosine kinase.
November 2019, Scientific reports,
Olivier Bornet, and Matthieu Nouailler, and Michaël Feracci, and Corinne Sebban-Kreuzer, and Deborah Byrne, and Hubert Halimi, and Xavier Morelli, and Ali Badache, and Françoise Guerlesquin
Determination of the substrate-docking site of protein tyrosine kinase C-terminal Src kinase.
December 2003, Proceedings of the National Academy of Sciences of the United States of America,
Olivier Bornet, and Matthieu Nouailler, and Michaël Feracci, and Corinne Sebban-Kreuzer, and Deborah Byrne, and Hubert Halimi, and Xavier Morelli, and Ali Badache, and Françoise Guerlesquin
Solution structure of the SH3 domain of Src and identification of its ligand-binding site.
December 1992, Science (New York, N.Y.),
Olivier Bornet, and Matthieu Nouailler, and Michaël Feracci, and Corinne Sebban-Kreuzer, and Deborah Byrne, and Hubert Halimi, and Xavier Morelli, and Ali Badache, and Françoise Guerlesquin
Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
February 1997, Nature,
Olivier Bornet, and Matthieu Nouailler, and Michaël Feracci, and Corinne Sebban-Kreuzer, and Deborah Byrne, and Hubert Halimi, and Xavier Morelli, and Ali Badache, and Françoise Guerlesquin
Son of sevenless binds to the SH3 domain of src-type tyrosine kinase.
October 1998, Molecules and cells,
Copied contents to your clipboard!